AbbVie M15-954 "VERONA"

MDS - VERONA

AbbVie M15-954 "VERONA"

Objective

Randomized, Double-Blind, Phase 3 Study Evaluating the Safety and Efficacy of Venetoclax in Combination with Azacitidine in Patients Newly Diagnosed with Higher-Risk Myelodysplastic Syndrome (Higher-Risk MDS)

Principal Investigator(s)
Vanessa Dickey, MD

Clinical Trial Categories

  • UCLA Trio Clinical Trials